Trade NBIX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Neurocrine Biosciences, Inc. (NBIX) is trading at US$146.23, down 3.69% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$15.51B. Over the past 52 weeks, NBIX has traded between US$122.14 and US$186.12. On Syfe you can trade NBIX with $0 commission and add it to your watchlist.
| Previous close | US$151.83 |
|---|---|
| Market cap | US$15.51B |
| P/E ratio | 16.26 |
| 52-week range | US$122.14 – US$186.12 |
| Volume | 2.81M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.
Year: 1996
Deutsche Bank Adjusts Neurocrine Biosciences PT to $165 From $190, Maintains Hold Rating
Aug 13, 11:25 AM · MT Newswires
Sector Update: Healthcare Stocks Rise Late Afternoon
Aug 7, 7:49 PM · MT Newswires
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Aug 7, 5:41 PM · MT Newswires
Sector Update: Healthcare
Aug 7, 5:13 PM · MT Newswires
Neurocrine Biosciences, Inc. (NBIX) stock is trading at US$146.23, -3.69% from the previous close of US$151.83.
The market cap for Neurocrine Biosciences, Inc. (NBIX) stock is approximately US$15.51B.
The price-to-earnings ratio for Neurocrine Biosciences, Inc. (NBIX) is 16.26, based on the latest reported earnings.
The 52-week high for Neurocrine Biosciences, Inc. (NBIX) stock is US$186.12.
The 52-week low for Neurocrine Biosciences, Inc. (NBIX) stock is US$122.14.
Neurocrine Biosciences, Inc. (NBIX) does not currently pay a dividend.
Stay on top of NBIX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
